Dumping ACEis/ARBs over COVID-19 concern? Not so fast
There is currently no definite evidence showing that two classes of antihypertensive medications — ACE inhibitors and ARBs* — are linked to increased risk of COVID-19 infection, leading experts say. On the contrary, what is clear is that stopping these medications simply because of concern over their perceived theoretical risk can come at a price of adverse cardiovascular (CV) events.
